Vectura has made three appointments to its business development team as part of its efforts to enhance its position as an inhalation specialist in the pharmaceutical services space.   Trevor Archbold and Robert Gurley have been appointed as Business Development Directors, and will have territorial responsibility for Europe and the U.S. West Coast respectively. Additionally, Chris Vernall will join Vectura in August as Business Development Director, and will work with Mr. Archbold in Europe. Al...